The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Global burden of alcoholic liver diseases
Open accessAbstract
Liver diseases contribute markedly to the global burden of mortality and disease. This paper provides an overview from a global perspective of the contribution of alcohol to liver diseases. The Global Burden of Disease study methodology was used to estimate the burden of alcohol-attributable liver cirrhosis and alcohol-attributable liver cancer in 2010 as measured by deaths and disability adjusted life years (DALYs). This methodology estimates attributable fractions based on alcohol exposure distribution and relative risks associated with different levels of drinking. Globally, in 2010, alcohol-attributable liver cirrhosis was responsible for 493,300 deaths (156,900 female deaths and 336,400 male deaths) and 14,544,000 DALYs (4,112,000 DALYs for women and 10,432,000 DALYs for men), representing 0.9% (0.7% for women and 1.2% for men) of all global deaths and 0.6% (0.4% for women and 0.8% for men) of all global DALYs, and 47.9% of all liver cirrhosis deaths (46.5% for women and 48.5% for men) and 46.9% of all liver cirrhosis DALYs (44.5% for women and 47.9% for men). Alcohol-attributable liver cancer was responsible for 80,600 deaths (14,800 female deaths and 65,900 male deaths) and 2,142,000 DALYs (335,000 DALYs for women and 1,807,000 DALYs for men). The burden of alcohol-attributable liver cirrhosis and liver cancer is high and entirely preventable. Interventions to reduce alcohol consumption are recommended as a population health priority and may range from taxation increases for alcoholic beverages to increases in screening and treatment rates for alcohol use disorders.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Liver disease is linked clearly to alcohol 277, evidenced by several ICD codes for alcoholic liver diseases (Table 1), including simple alcoholic steatosis, hepatitis, fibrosis and cirrhosis and superimposed hepatocellular carcinoma, which is part of alcohol‐attributable cancers (see above).”
From The relationship between different dimensions of alcohol use and the burden of disease—an update (2017) · cites this paper as [277]
Citations
Cites
Lozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Lim, S. S., Vos, T., Flaxman, A. D., Danaei, G., Shibuya, K., Adair-Rohani, H., AlMazroa, M. A., Amann, M., Anderson, H. R., Andrews, K. G., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61766-8 · Cited by 11,805
Murray, C. J. L., Vos, T., Lozano, R., Naghavi, M., Flaxman, A. D., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61689-4 · Cited by 8,888
Global status report on noncommunicable diseases 2010.
Alwan, A. (2011) · Cited by 8,494
Vos, T., Flaxman, A. D., Naghavi, M., Lozano, R., Michaud, C., Ezzati, M., Shibuya, K., Salomon, J. A., Abdalla, S., Aboyans, V., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61729-2 · Cited by 8,291
Ezzati, M., López, A. D., Rodgers, A., & Murray, C. J. L. (2004) · Cited by 3,319
Global Burden of Disease and Risk Factors
López, A. D., Mathers, C. D., Ezzati, M., Jamison, D. T. T., & Murray, C. J. L. (2006) · World Bank, Washington, DC eBooks · doi:10.1596/978-0-8213-6262-4 · Cited by 2,714
Alcohol: No Ordinary Commodity. Research and public policy
Babor, T. F., Caetano, R., Casswell, S., Edwards, G., Giesbrecht, N., Graham, K., Grube, J. W., Hill, L., Holder, H. D., Homel, R. J., et al. (2003) · Cited by 1,718
Self-citationUse and misuse of population attributable fractions
Rockhill, B., Newman, B., & Weinberg, C. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.1.15 · Cited by 1,683
Nonalcoholic fatty liver disease
Adams, L. A. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.045232 · Cited by 1,658
Flagged first, then by citations
Research works printed but not linked: 1
- Kehoe, 2012, Determining the best population-level alcohol consumption model and its impact on estimates of alcohol-attributable harms, Popul Health Metrics, 10, 6, 10.1186/1478-7954-10-6 · DOI · Paper page
Cited by
Sorted by citations
Items 201–300 of 738
Hagström, H., Hegmar, H., & Moreno, C. (2024) · United European Gastroenterology Journal · doi:10.1002/ueg2.12524 · Cited by 40
Tomato lycopene prevention of alcoholic fatty liver disease and hepatocellular carcinoma development
Stice, C. P., Xia, H., & Wang, X. (2018) · Chronic Diseases and Translational Medicine · doi:10.1016/j.cdtm.2018.11.001 · Cited by 40
Innate gut microbiota predisposes to high alcohol consumption
Ezquer, F. E., Quintanilla, M. E., Moya‐Flores, F., Morales, P., Munita, J. M., Olivares, B., Landskron, G., Hermoso, M. A., Ezquer, M., Herrera‐Marschitz, M., et al. (2021) · Addiction Biology · doi:10.1111/adb.13018 · Cited by 43
Lucey, M. R. (2019) · Clinics in Liver Disease · doi:10.1016/j.cld.2018.09.013 · Cited by 39
Li, J., Yang, C. N., Zhang, S., Liu, S., Zhao, L., Luo, H., Chen, Y., & Huang, W. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3297 · Cited by 39
Zhang, Y., Guo, T., Yang, F., Mao, Y., Li, L., Liu, C., Sun, Q., Li, Y., & Huang, J. (2018) · Hepatology International · doi:10.1007/s12072-018-9889-3 · Cited by 39
Noureddin, M., Sander‐Struckmeier, S., & Mato, J. M. (2020) · World Journal of Hepatology · doi:10.4254/wjh.v12.i2.46 · Cited by 39
Ubiquitin pathways regulate the pathogenesis of chronic liver disease
Park, J.-S., Ma, H., & Roh, Y. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114764 · Cited by 40
Sex differences in chronic liver disease and benign liver lesions
Cooper, K. M., Delk, M., Devuni, D., & Sarkar, M. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100870 · Cited by 38
Nwidu, L. L., Elmorsy, E. M., Oboma, Y. I., & Carter, W. G. (2018) · Journal of Taibah University Medical Sciences · doi:10.1016/j.jtumed.2018.03.006 · Cited by 43
Askgaard, G., Kjær, M. S., & Tolstrup, J. S. (2018) · The American Journal of Gastroenterology · doi:10.1038/s41395-018-0282-6 · Cited by 38
Teschke, R., Eickhoff, A., Brown, A. C., Neuman, M. G., & Schulze, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010212 · Cited by 30
Pharmacotherapy of alcoholic liver disease in clinical practice
Rosato, V., Abenavoli, L., Federico, A., Masarone, M., & Persico, M. (2015) · International Journal of Clinical Practice · doi:10.1111/ijcp.12764 · Cited by 37
Hepatic Retinyl Ester Hydrolases and the Mobilization of Retinyl Ester Stores
Grumet, L., Taschler, U., & Lass, A. (2016) · Nutrients · doi:10.3390/nu9010013 · Cited by 40
Melatonin ameliorates alcohol‐induced bile acid synthesis by enhancing miR‐497 expression
Kim, Y. D., Hwang, S., Lee, E., Kim, H., Chung, M.-J., Elfadl, A. K., Lee, S., Nedumaran, B., Harris, R. A., & Jeong, K. (2017) · Journal of Pineal Research · doi:10.1111/jpi.12386 · Cited by 37
Genetic and Epigenetic Profile of Patients With Alcoholic Liver Disease
Boccuto, L., & Abenavoli, L. (2017) · Annals of Hepatology · doi:10.5604/01.3001.0010.0274 · Cited by 36
Westwood, G., Meredith, P., Atkins, S., Greengross, P., Schmidt, P. E., & Aspinall, R. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2017.04.017 · Cited by 37
Aspirin and the risk of hepatocellular carcinoma development in patients with alcoholic cirrhosis
Shin, S., Lee, S. H., Lee, M., Kim, J. H., Lee, W., Lee, H. W., Park, M. S., Park, S. W., Kim, T. S., & Choi, D. H. (2020) · Medicine · doi:10.1097/md.0000000000019008 · Cited by 37
Patel, F., Parwani, K., Patel, D. N., & Mandal, P. (2021) · Mediators of Inflammation · doi:10.1155/2021/6636152 · Cited by 37
Xu, H., Xiao, P., Zhang, F., Liu, T., & Gao, Y. (2022) · Liver International · doi:10.1111/liv.15312 · Cited by 37
Murine Models of Acute Alcoholic Hepatitis and Their Relevance to Human Disease
Wilkin, R. J. W., Lalor, P. F., Parker, R., & Newsome, P. N. (2016) · The American Journal of Pathology · doi:10.1016/j.ajpath.2015.12.003 · Cited by 36
Kouno, T., Zeng, S.-L., Wang, Y., Duan, Y., Lang, S., Gao, B., Hartmann, P., Cabré, N., Llorente, C., Galbert, C., et al. (2023) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.15048 · Cited by 36
Danpanichkul, P., Ng, C. H., Muthiah, M. D., Suparan, K., Tan, D. J. H., Duangsonk, K., Sukphutanan, B., Kongarin, S., Harinwan, N., Panpradist, N., et al. (2023) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002642 · Cited by 37
Yang, L., Chen, Y., Pan, W., Wang, H., Li, N., & Tang, B. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.7b01144 · Cited by 36
Wu, Y. C., Huang, H. H., Wu, Y. J., Manousakas, I., Yang, C. C., & Kuo, S. M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20164057 · Cited by 36
Liver Metabolomics Reveals the Effect of Lactobacillus reuteri on Alcoholic Liver Disease
Zheng, T., Pu, S.-L., Tan, P., Du, Y., Qian, B., Chen, H., Fu, W., & Huang, M. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.595382 · Cited by 36
Unlocking the Pharmacological Potential of Myricetin Against Various Pathogenesis
Almatroodi, S. A., & Rahmani, A. H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26094188 · Cited by 41
El‐Sisi, A. E., Sokar, S. S., Shebl, A. M., & Mohamed, D. Z. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.03.013 · Cited by 37
Fang, C., Du, H., Zheng, X., Zhao, A., Jia, W. P., & Xu, Y. (2019) · The FASEB Journal · doi:10.1096/fj.201802306r · Cited by 38
Liver cancer prediction in a viral hepatitis cohort: A deep learning approach
Phan, D., Chan, C., Li, A. A., Chien, T., & Nguyen, V. (2020) · International Journal of Cancer · doi:10.1002/ijc.33245 · Cited by 39
Madsen, B. S., Thiele, M. S., Detlefsen, S., Kjærgaard, M., Møller, L. S., Trebicka, J., Nielsen, M. J., Gudmann, N. S., Leeming, D. J., Karsdal, M. A., et al. (2021) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16513 · Cited by 35
Zhang, P., Wang, W., Mao, M., Gao, R., Shi, W., Li, D., Calderone, R., Sui, B., Tian, X., & Meng, X. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.710285 · Cited by 38
The Human Gut Microbiome in Liver Diseases
Davis, B., & Bajaj, J. (2017) · Seminars in Liver Disease · doi:10.1055/s-0037-1602763 · Cited by 34
Liver cirrhosis in 2021: Global Burden of Disease study
Duo, H., You, J., Du, S., Yu, M., Wu, S., Yue, P., Cui, X., Huang, Y., Luo, J., Pan, H., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0328493 · Cited by 46
Ultrasound-based elastography for the diagnosis of portal hypertension in cirrhotics
Șirli, R. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i41.11542 · Cited by 34
Wang, Y., Zhang, Z., Wang, X., Qi, D., Qu, A., & Wang, G. (2017) · Mediators of Inflammation · doi:10.1155/2017/3526903 · Cited by 34
A novel role for ceramide synthase 6 in mouse and human alcoholic steatosis
Williams, B., Correnti, J. M., Oranu, A. C., Lin, A., Scott, V. M., Annoh, M., Beck, J., Furth, E. E., Mitchell, V., Senkal, C. E., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201601142r · Cited by 34
LncRNA Gm5091 alleviates alcoholic hepatic fibrosis by sponging miR‐27b/23b/24 in mice
Zhou, B., Yuan, W., & Li, X. (2018) · Cell Biology International · doi:10.1002/cbin.11021 · Cited by 35
Cheng, M., Zhu, J., Ren, T., & Zhou, M. (2016) · Drug Design Development and Therapy · doi:10.2147/dddt.s102883 · Cited by 33
Jinjuvadia, R., Jinjuvadia, C., Puangsricharoen, P., Chalasani, N., Crabb, D. W., & Liangpunsakul, S. (2017) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13567 · Cited by 33
Xie, Z.-Y., Xiao, Z.-H., & Wang, F. (2018) · Biochimie · doi:10.1016/j.biochi.2017.12.013 · Cited by 33
MicroRNAs in alcoholic liver disease: Recent advances and future applications
Xu, T., Li, L., Hu, H., Meng, X., Huang, C. Z., Zhang, L., Qin, J., & Li, J. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26938 · Cited by 33
Lee, K.-C., Chen, P., Maričić, I., Inamine, T., Hu, J.-J., Gong, S.-H., Sun, J. C., Dasgupta, S., Lin, H.-C., Lin, Y.-T., et al. (2019) · American Journal of Physiology - Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00269.2018 · Cited by 32
Xue, M., Liang, H., Zhou, Z., Liu, Y., He, X., Zhang, Z., Sun, T., Yang, J., Qin, Y., & Qin, K. (2021) · Food & Nutrition Research · doi:10.29219/fnr.v65.5384 · Cited by 33
Zhu, Y. T., Li, D., Ye, T., Qiu, F., Wang, X.-L., Yan, X., Lu, Y., Wei, X., Li, H., & Hu, X. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/8917993 · Cited by 33
Spectrum, Screening, and Diagnosis of Alcohol-related Liver Disease
Hernández‐Tejero, M., Clemente, A. P. G., & Bataller, R. A. (2022) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2022.10.002 · Cited by 33
Fu, R., Zhou, J., Wang, R., Sun, R., Feng, D., Wang, Z., Zhao, Y., Lv, L., Tian, X., & Yao, J. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/3527809 · Cited by 32
Targeting Unmet Clinical Needs in the Treatment of Alcohol Use Disorder
Lohoff, F. W. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.767506 · Cited by 37
Singhvi, A., Welch, A. N., Levitsky, J., Singhvi, D., & Gordon, E. J. (2016) · The AMA Journal of Ethic · doi:10.1001/journalofethics.2016.18.2.sect1-1602 · Cited by 32
Lee, J. S., O’Connell, E. M., Pacher, P., & Lohoff, F. W. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10081758 · Cited by 31
Bibliometric study of immunotherapy for hepatocellular carcinoma
Li, Z., Zhang, Y., Zhang, B., Guo, R., Min-Hua, H., Liu, Z., Yang, L., & Wang, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1210802 · Cited by 33
Haghgoo, S. M., Sharafi, H., & Alavian, S. M. (2018) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2018-0357 · Cited by 31
Dimethyl fumarate ameliorates hepatic inflammation in alcohol related liver disease
Sangineto, M., Grabherr, F., Adolph, T. E., Grander, C., Reider, S., Jaschke, N., Mayr, L., Schwärzler, J., Dallio, M., Moschen, A. R., et al. (2020) · Liver International · doi:10.1111/liv.14483 · Cited by 32
Impact of alcohol on mortality in Eastern Europe: Trends and policy responses
Jasilionis, D., Leon, D. A., & Pechholdová, M. (2020) · Drug and Alcohol Review · doi:10.1111/dar.13167 · Cited by 31
Liu, S.-X., Liu, H., Wang, S., Zhang, C., Guo, F., & Zeng, T. (2022) · Food and Chemical Toxicology · doi:10.1016/j.fct.2022.113108 · Cited by 31
Siddiqui, M. S., & Charlton, M. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.02.077 · Cited by 30
Morley, K. C., Baillie, A., van den Brink, W., Chitty, K. M., Brady, K. T., Back, S. E., Seth, D., Sutherland, G. T., Leggio, L., & Haber, P. (2018) · Expert Opinion on Investigational Drugs · doi:10.1080/13543784.2018.1501471 · Cited by 29
Shuai, C., Xia, G., Yuan, F., Wang, S., & Lv, X. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174198 · Cited by 30
Lin, Y., Chen, H., Cao, Y.-J., Zhang, Y., Li, W., Guo, W., Lv, X., Rao, P., Ni, L., & Liu, P. (2021) · Foods · doi:10.3390/foods10102436 · Cited by 30
One-month alcohol abstinence national campaigns: a scoping review of the harm reduction benefits
de Ternay, J., Leblanc, P., Michel, P., Benyamina, A., Naassïla, M., & Rolland, B. (2022) · Harm Reduction Journal · doi:10.1186/s12954-022-00603-x · Cited by 31
Pace, C. A., & Samet, J. H. (2016) · Annals of Internal Medicine · doi:10.7326/aitc201604050 · Cited by 30
Swanson, A. C., Geller, J., DeMartini, K. S., Fernandez, A. C., & Fehon, D. C. (2018) · Journal of Clinical Psychology in Medical Settings · doi:10.1007/s10880-018-9559-6 · Cited by 30
Liu, L., Xie, P., Li, W., Wu, Y., & An, W. (2018) · American Journal Of Pathology · doi:10.1016/j.ajpath.2018.11.006 · Cited by 29
An effective approach for early liver disease prediction and sensitivity analysis
Khan, M. A. R., Afrin, F., Prity, F. S., Ahammad, I., Fatema, S., Prosad, R., Hasan, M. K., Uddi̇n, M., & Salehin, Z. U. (2023) · Iran Journal of Computer Science · doi:10.1007/s42044-023-00138-9 · Cited by 29
Non-invasive assessment of liver fibrosis in patients with alcoholic liver disease
Lombardi, R. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i39.11044 · Cited by 29
Parker, R., Im, G. Y., Jones, F., Hernández, O. P., Nahas, J., Kumar, A., Wheatley, D., Sinha, A., González‐Reimers, E., Sanchez-Pérez, M., et al. (2017) · Journal of Gastroenterology · doi:10.1007/s00535-017-1336-z · Cited by 30
Chen, X., Ying, X., Sun, W., Zhu, H., Jiang, X., & Chen, B. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.01.027 · Cited by 29
Xu, L., Li, W., Chen, S., Deng, X.-W., Deng, W.-F., Liu, G., Chen, Y., & Cao, Y. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.1053718 · Cited by 29
Synthetic Biology-Driven Microbial Therapeutics for Disease Treatment
Kim, T. H., Cho, B., & Lee, D. (2024) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.2407.07004 · Cited by 32
Decreasing Mortality Among Danish Alcoholic Cirrhosis Patients: A Nationwide Cohort Study
Deleuran, T., Vilstrup, H., & Jepsen, P. (2016) · The American Journal of Gastroenterology · doi:10.1038/ajg.2016.107 · Cited by 28
Su, Q.-Q., Tian, Y., Liu, Z., Ci, L., & Lv, X. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.11.012 · Cited by 28
Gluco-metabolic effects of oral and intravenous alcohol administration in men
Lanng, A. R., Gasbjerg, L. S., Bergmann, N. C., Bergmann, S., Helsted, M. M., Gillum, M. P., Hartmann, B., Holst, J. J., Vilsbøll, T., & Knop, F. K. (2019) · Endocrine Connections · doi:10.1530/ec-19-0317 · Cited by 30
Bataller, R. A., Cabezas, J., Aller, R., Cots, M. V., Abad, J., Albillos, A., Altamirano, J., Arias, M., Bañares, R., Caballería, J., et al. (2019) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2019.09.006 · Cited by 28
Warner, J. B., Guenthner, S. C., Hardesty, J., McClain, C. J., Warner, D. R., & Kirpich, I. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i36.5280 · Cited by 31
Goikoetxea‐Usandizaga, N., Bravo, M., Egia‐Mendikute, L., Abecia, L., Serrano‐Maciá, M., Urdinguio, R. G., Clos‐Garcia, M., Agudo, R. R., Legido, R. A., López-Bermudo, L., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000303 · Cited by 28
Fatty Liver Disease, Metabolism and Alcohol Interplay: A Comprehensive Review
Odriozola, A., Santos‐Laso, Á., Barrio, M. D., Cabezas, J., Iruzubieta, P., Arias, M., Rivas, C., Duque, J. C. R., Antón, Á., Fábrega, E., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097791 · Cited by 29
A Laughing Matter? How Humor in Alcohol Ads Influences Interpersonal Communication and Persuasion
Hendriks, H., & Strick, M. (2019) · Health Communication · doi:10.1080/10410236.2019.1663587 · Cited by 28
Meta‐analysis: Prevalence and impact of alcohol abstinence in alcohol‐associated cirrhosis
Lim, W. H., Tay, P. W. L., Ng, C. H., Tan, D. J. H., Ong, C. E. Y., Koh, J. H., Teng, M. L. P., Chee, D., Wong, Z. Y., Kawaguchi, T., et al. (2024) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17888 · Cited by 27
Krepkova, L. V., Babenko, A. N., Saybel, O. L., Лупанова, И. А., Kuzina, O. S., Job, K. M., Sherwin, C. M. T., & Enioutina, E. Y. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.738504 · Cited by 27
Xiang, Z., Wu, J., Li, J., Zheng, S., Wei, X., & Xu, X. (2023) · Engineering · doi:10.1016/j.eng.2022.12.012 · Cited by 27
Gut–liver axis alterations in alcoholic liver disease: Are bile acids the answer?
Bajaj, J. S., & Hylemon, P. B. (2017) · Hepatology · doi:10.1002/hep.29760 · Cited by 27
Yao, Y., Zhang, W., Ming, R., Deng, Q., Zuo, A., Zhang, S., Ying, Y., Zhao, Y., & Ma, J. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00355 · Cited by 28
Han, S., Zhang, T., Kusumanchi, P., Huda, N., Jiang, Y., Yang, Z., & Liangpunsakul, S. (2020) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2020.0166 · Cited by 26
The role of acetaldehyde dehydrogenase 2 in the pathogenesis of liver diseases
Wu, Y., Yao, Y., Tao, L.-S., Wang, S., Hu, Y. J., Li, L., Hu, S., Meng, X., Yang, D., Li, H., et al. (2022) · Cellular Signalling · doi:10.1016/j.cellsig.2022.110550 · Cited by 26
PNPLA3 genetic variation in alcoholic steatosis and liver disease progression.
Stickel, F., Hampe, J., Trépo, E., Datz, C., & Romeo, S. (2015) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2304-3881.2014.11.04 · Cited by 26
Thompson, K. J., Humphries, J. R., Niemeyer, D. J., Sindram, D., & McKillop, I. H. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-09614-8_21 · Cited by 26
Hepatoprotective effect of Gan Kang Yuan against chronic liver injury induced by alcohol
Guo, Y., Zhao, Q., Cao, L., & Zhao, B. (2017) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2017.06.033 · Cited by 26
Mucosal-Associated Invariant T cell in liver diseases
Zhang, Y., Kong, D., & Wang, H. (2020) · International Journal of Biological Sciences · doi:10.7150/ijbs.39016 · Cited by 26
Kuo, C., Li, C., Chuang, M., Huang, P., Kuo, H., & Lai, C. (2025) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.70007 · Cited by 26
The future of liver transplantation for viral hepatitis
Durand, F., & Francoz, C. (2017) · Liver International · doi:10.1111/liv.13310 · Cited by 25
Ethnopharmacological Applications Targeting Alcohol Abuse: Overview and Outlook
Singh, L., Joshi, T., Tewari, D., Echeverría, J., Mocan, A., Sah, A. N., Parvanov, E. D., Tzvetkov, N. T., Feei, Z., Lee, Y. Y., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01593 · Cited by 26
Alfayad, K., Murray, R. L., Britton, J. R., & Barker, A. B. (2021) · Journal of Public Health · doi:10.1093/pubmed/fdab022 · Cited by 25
Mortality associated with alcohol-related liver disease
Trimble, G., Zheng, L., Mishra, A., Kalwaney, S., Mir, H. M., & Younossi, Z. M. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12432 · Cited by 26
Wu, Z., Wang, W., Zhang, K., Fan, M., & Lin, R. (2023) · Journal of Medical Virology · doi:10.1002/jmv.28858 · Cited by 23
Song, D. S., Chang, U. I., Choi, S., Jung, Y. D., Han, K., Ko, S., Ahn, Y., & Yang, J. M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0163222 · Cited by 24
Rodent models of fatty liver diseases
Bertola, A. (2018) · Liver Research · doi:10.1016/j.livres.2018.03.001 · Cited by 23
Gao, M., Huang, A., Sun, Z., Sun, Y. H., Chang, B., Zhang, J., & Zou, Z. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14109 · Cited by 24
Barré, T., Marcellin, F., Beo, V. D., Delorme, J., Rojas, T. R., Mathurin, P., Protopopescu, C., Bailly, F., Coste, M., Authier, N., et al. (2019) · Addiction · doi:10.1111/add.14820 · Cited by 24
Xiao, C., Zhou, F., Zheng, L. P., Cai, Y., Su, G., Luo, D., & Zhao, M. (2020) · Food Research International · doi:10.1016/j.foodres.2020.109592 · Cited by 24
Song, C., Chen, H., Yu, B., Zhang, L., Wang, J., Feng, C., Yang, X., Tian, X., Fan, Y., Ji, X., et al. (2023) · Research · doi:10.34133/research.0097 · Cited by 24
Metadata
- Authors
- Rehm, J., Samokhvalov, A. V., & Shield, K. D.
- Affiliations
- Centre for Addiction and Mental Health (CA)
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2013-07
- Volume
- 59
- Issue
- 1
- Pages
- 160-168
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2048180954
- Cited by
- 740
- References
- 59
- Citations by year
- 2026: 25 · 2025: 47 · 2024: 42 · 2023: 53 · 2022: 67 · 2021: 61 · 2020: 89 · 2019: 76 · 2018: 74 · 2017: 73 · 2016: 50 · 2015: 55 · 2014: 23 · 2013: 4
- FWCI
- 6.45
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Hepatology (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Ontario Ministry of Health and Long-Term Care
- Canadian Institutes of Health Research
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Global Public Health Policies and Epidemiology
- Keywords
- alcoholic liver disease, liver cirrhosis, liver cancer, disability-adjusted life years, alcohol consumption, attributable fraction, alcohol taxation, global burden of disease
- MeSH terms
- Alcohol Drinking, Female, Humans, Liver Cirrhosis, Alcoholic, Liver Diseases, Alcoholic, Liver Neoplasms, Male, Risk Factors, Sex Factors, Global Health, Quality-Adjusted Life Years
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
